MAGEA1 and ovarian carcinoma: Steele et al.25found that the expression of MAGE‐A1 significantly increased in vitro and in vivo after the ovarian cancer platinum‐resistant cell line A2780/cp70 treated with DAC and HDAC inhibitors.